Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European ...

Celltrion announced on the 24th that it has received product approval from the European Commission (EC) for ACTEMRA ...

Kiwoom Securities and Koramco Asset Management have participated in the refinancing of a 380 billion won real estate project ...

At this week's board meeting, Germany and Sweden encouraged wealthier developing nations to step up - an idea rejected by ...

Kenya is set to receive Sh4.7 billion ($36 million) from donors that will benefit more than 2.7 million people in the Lake ...

Songdo/Rome - The Green Climate Fund (GCF) has approved funding for two new projects valued at over $130 million to bolster ...

Busan, one of South Korea’s most renown and vibrant coastal city, offers a mix of seasons, options, and selections for ...

The Green Climate Fund (GCF) will host the 41st meeting of the GCF Board (B.41) in Songdo, Incheon, Republic of Korea from February 17 to 20, 2025.  Twelve new climate projects totalling $736.8 ...

Celltrion’s plan to build a new drug product plant in Incheon's Songdo received approval from local authorities, the ...

Celltrion announced on Friday that it has received construction approval to build a new drug product (DP) manufacturing plant in Songdo, Incheon. The new facility, permitted by the Incheon Free ...